GSK3B and adenosquamous carcinoma: GSK3β has been shown to be expressed at lower levels in skin cancer tumours and knockdown of GSK3β in breast cancer mammary models results in activation of Wnt signalling and the formation of adenosquamous carcinomas [5, 6].